medigraphic.com
SPANISH

Mediciego

ISSN 1029-3035 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 3

<< Back Next >>

Mediciego 2018; 24 (3)

Clinical, epidemiological and metabolic characteristics in type 2 diabetics newly diagnosed with insulin as transitory therapy

Cajigal PY, Arguelles MO, Roque MM, Artiles PE
Full text How to cite this article

Language: Spanish
References: 0
Page: 4-13
PDF size: 148.52 Kb.


Key words:

type 2 diabetes mellitus/physiopathology, type 2 diabetes mellitus/epidemiology, type 2 diabetes mellitus/metabolism, insulin/administration and dosage, observational study.

ABSTRACT

Introduction: in patients with type 2 diabetes mellitus, initial treatment with insulin is a therapeutic modality used.
Objective: to characterize clinically, epidemiologically and metabolically patients with type 2 diabetes mellitus with transient use of insulin after diagnosis.
Method: a prospective descriptive observational study was carried out in the General Provincial Teaching Hospital of Ciego de Ávila during the period from May 2015 to July 2016. From a population of 131 patients with diabetes mellitus type 2, an intentional sample of 67 was taken, which insulin was indicated transiently after diagnosis.
Results: the average age was 48,90 years. Women predominated (56,71%) and family history (94,02%). The mean insulin dose was 29,60±6,20 Ud/day in 42,90 ± 9,3 days. There was significant improvement between the onset and six months: body mass index (30,80±2,3-28,60± 2,06); circumference of the abdominal waist (men 108,3 ± 7,8-103,30 ± 6,20 cm and women 103,60±7,10-100,10±5,70 cm); fasting blood glucose (13,60±1,30 mmol/L y PP2h: 22,10± 2,80-10±0,70 mmol/L and7,90±1,10 mmol/L) and glucocylated hemoglobin (8,70±1,10-6,90± 0,60%). Hypoglycaemias were few: 2,90% moderate and 5,90% light. The almost totality was controlled with metformin at six months (92,54%).
Conclusions: the results confirm that with the initial transient use of insulin an adequate glycemic control is achieved, subsequently maintained with metformin monotherapy.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Mediciego. 2018;24